The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Open accessAbstract
Alzheimer’s Disease (AD) represents a major and rapidly growing burden to the healthcare ecosystem. A growing body of evidence indicates that cognitive, behavioral, sensory, and motor changes may precede clinical manifestations of AD by several years. Existing tests designed to diagnose neurodegenerative diseases, while well-validated, are often less effective in detecting deviations from normal cognitive decline trajectory in the earliest stages of the disease. In the quest for gold standards for AD assessment, there is a growing interest in the identification of readily accessible digital biomarkers, which harness advances in consumer grade mobile and wearable technologies. Topics examined include a review of existing early clinical manifestations of AD and a path to the respective sensor and mobile/wearable device usage to acquire domain-centric data towards objective, high frequency and passive digital phenotyping.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Complementary digital biomarkers derived from handwriting, speech, and environmental sensors further enable longitudinal tracking of cognitive decline (Kourtis et al., 2019).”
From Multimodal neuroimaging and AI integration in cognitive disorders: advances, challenges, and future directions for precision medicine (2026) · cites this paper as Kourtis et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“early detection of neurodegenerative disorders such as Alzheimer’s disease (AD), in which key indices of preclinical stages are cognitive, motor and sensory changes that occur 10 or 15 years prior to its effective diagnosis43,44.”
From Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare (2020) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Monitoring these biomarkers’ fluctuations is essential in the early detection and treatment of mental health disorders [3,32].”
From Predicting Depression From Smartphone Behavioral Markers Using Machine Learning Methods, Hyperparameter Optimization, and Feature Importance Analysis: Exploratory Study (2021) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While classification tasks are common in automated speech analysis in neurodegenerative research, several studies have employed regression models to predict continuous cognitive outcomes (e.g., MMSE)97,98 or to explore relationships with imaging and biomarker measures.99–101”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,120
Thayer, J. F., Åhs, F., Fredrikson, M., Sollers, J. J., & Wager, T. D. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.11.009 · Cited by 3,224
Executive functions and self-regulation
Hofmann, W., Schmeichel, B. J., & Baddeley, A. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.01.006 · Cited by 1,965
Thayer, J. F., Hansen, A. L., Saus-Rose, E., & Johnsen, B. H. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9101-z · Cited by 1,872
Inferring friendship network structure by using mobile phone data
Eagle, N., Pentland, A. (., & Lazer, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900282106 · Cited by 1,856
Elhai, J. D., Dvorak, R. D., Levine, J. C., & Hall, B. J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.030 · Cited by 1,689
The Rise of Consumer Health Wearables: Promises and Barriers
Piwek, L., Ellis, D. A., Andrews, S., & Joinson, A. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001953 · Cited by 1,235
Attention and executive deficits in Alzheimer's disease: A critical review
Perry, R. J. (1999) · Brain · doi:10.1093/brain/122.3.383 · Cited by 1,180
Muro-de-la-Herran, A., Garcia-Zapirain, B., & Mendez-Zorrilla, A. (2014) · Sensors · doi:10.3390/s140203362 · Cited by 1,172
The spectrum of behavioral changes in Alzheimer's disease
Mega, M. S., Cummings, J. L., Fiorello, T., & Gornbein, J. (1996) · Neurology · doi:10.1212/wnl.46.1.130 · Cited by 1,115
Research works printed but not linked: 1
- Vitiello, M. V. & Borson, S. Sleep disturbances in patients with Alzheimer’s disease. Mol. Diag Ther. 15, 777–796 (2001).
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Goldsack, J. C., Coravos, A., Bakker, J. P., Bent, B., Dowling, A. V., Fitzer-Attas, C., Godfrey, A., Godino, J. G., Gujar, N., Izmailova, E., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0260-4 · Cited by 557
Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare
Cirillo, D., Catuara-Solarz, S., Morey, C., Guney, E., Subirats, L., Mellino, S., Gigante, A., Valencia, A., Rementeria, M. J., Chadha, A. S., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0288-5 · Cited by 553
A Survey on Wearable Technology: History, State-of-the-Art and Current Challenges
Ometov, A., Shubina, V., Klus, L., Skibińska, J., Saafi, S., Pascacio, P., Flueratoru, L., Gaibor, D. Q., Chukhno, N., Chukhno, O., et al. (2021) · Computer Networks · doi:10.1016/j.comnet.2021.108074 · Cited by 506
Brown, E. E., Kumar, S., Rajji, T. K., Pollock, B. G., & Mulsant, B. H. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.04.010 · Cited by 483
“[38] [39] [40] In the field of ADRD research, we believe it will impact most the traditional neuropsychological and functional assessments on which most primary outcomes for ADRD interventions trials are based.”
Background
Metadata
- Authors
- Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B.
- Affiliations
- Tufts University (US)
- Eli Lilly (United States) (US)
- Corresponding author
- Kourtis, Lampros C.
- Jones, Graham B.
- Venue
- npj Digital Medicine
- Published
- 2019-02-21
- Volume
- 2
- Issue
- 1
- ISSN
- 2398-6352 (ISSN-L)
- PMC
- PMC6526279
- OpenAlex
- W2917347002
- Cited by
- 476
- References
- 99
- Citations by year
- 2026: 75 · 2025: 105 · 2024: 71 · 2023: 60 · 2022: 60 · 2021: 57 · 2020: 35 · 2019: 12
- FWCI
- 32.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Digital Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002544)
- National Center for Advancing Translational Sciences (NIH UL1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- Alzheimer's disease, digital biomarkers, mobile devices, wearable sensors, digital phenotyping, early detection, cognitive decline, neurodegenerative diseases, passive sensing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. https://app.cochat.ai/papers/10.1038/s41746-019-0084-2
- The paper
- Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019). Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. npj Digital Medicine. https://doi.org/10.1038/s41746-019-0084-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.